Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors ‐ a VALIDATE‐SWEDEHEART Substudy

Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors ‐ a VALIDATE‐SWEDEHEART Substudy

Background The clinical importance of intraprocedural stent thrombosis (IPST) during percutaneous coronary intervention in the contemporary era of potent oral P2Y12 inhibitors is not established. The aim of this study was to assess IPST and its association with clinical outcome in patients with myoc...

Full description

Bibliographic Details
Main Authors: Sofia Bergman, Moman A. Mohammad, Stefan K. James, Oskar Angerås, Henrik Wagner, Jens Jensen, Fredrik Scherstén, Ole Fröbert, Sasha Koul, David Erlinge
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
intraprocedural stent thrombosis
myocardial infarction
oral P2Y12 inhibitors
percutaneous coronary intervention
stent thrombosis
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.022984

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.022984

Similar Items